Jeff Yass’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-535
| Closed | -$15K | – | 12600 |
|
|
2022
Q3 | $15K | Sell |
535
-250
| -32% | -$9.8K | ﹤0.01% | 12695 |
|
|
2022
Q2 | $34K | Buy |
+785
| New | +$36K | ﹤0.01% | 12161 |
|
|
2022
Q1 | – | Sell |
-880
| Closed | -$74K | – | 13116 |
|
|
2021
Q4 | $74K | Sell |
880
-1,820
| -67% | -$204K | ﹤0.01% | 12330 |
|
|
2021
Q3 | $438K | Sell |
2,700
-2,845
| -51% | -$462K | ﹤0.01% | 9724 |
|
|
2021
Q2 | $837K | Sell |
5,545
-2,145
| -28% | -$361K | ﹤0.01% | 8251 |
|
|
2021
Q1 | $1.34M | Buy |
7,690
+5,220
| +211% | +$995K | ﹤0.01% | 6961 |
|
|
2020
Q4 | $394K | Buy |
2,470
+230
| +10% | +$38.5K | ﹤0.01% | 8758 |
|
|
2020
Q3 | $357K | Sell |
2,240
-40
| -2% | -$7.22K | ﹤0.01% | 8358 |
|
|
2020
Q2 | $451K | Sell |
2,280
-1,195
| -34% | -$219K | ﹤0.01% | 7572 |
|
|
2020
Q1 | $537K | Buy |
3,475
+2,765
| +389% | +$279K | ﹤0.01% | 6781 |
|
|
2019
Q4 | $55K | Buy |
+710
| New | +$61.9K | ﹤0.01% | 9321 |
|
|
2019
Q2 | – | Sell |
-760
| Closed | -$115K | – | 10286 |
|
|
2019
Q1 | $115K | Buy |
+760
| New | +$118K | ﹤0.01% | 8187 |
|
|
2018
Q3 | – | Sell |
-610
| Closed | -$139K | – | 9342 |
|
|
2018
Q2 | $139K | Sell |
610
-85
| -12% | -$16.1K | ﹤0.01% | 8891 |
|
|
2018
Q1 | $98K | Sell |
695
-730
| -51% | -$110K | ﹤0.01% | 8712 |
|
|
2017
Q4 | $185K | Sell |
1,425
-1,360
| -49% | -$173K | ﹤0.01% | 8337 |
|
|
2017
Q3 | $345K | Sell |
2,785
-720
| -21% | -$73.4K | ﹤0.01% | 7155 |
|
|
2017
Q2 | $301K | Buy |
3,505
+1,560
| +80% | +$137K | ﹤0.01% | 7590 |
|
|
2017
Q1 | $175K | Buy |
1,945
+1,440
| +285% | +$161K | ﹤0.01% | 8108 |
|
|
2016
Q4 | $55K | Sell |
505
-200
| -28% | -$21.9K | ﹤0.01% | 9263 |
|
|
2016
Q3 | $90K | Sell |
705
-510
| -42% | -$53K | ﹤0.01% | 7975 |
|
|
2016
Q2 | $111K | Buy |
1,215
+255
| +27% | +$22.2K | ﹤0.01% | 7970 |
|
|
2016
Q1 | $75K | Sell |
960
-485
| -34% | -$42.1K | ﹤0.01% | 8540 |
|
|
2015
Q4 | $161K | Sell |
1,445
-1,190
| -45% | -$162K | ﹤0.01% | 8598 |
|
|
2015
Q3 | $333K | Sell |
2,635
-1,040
| -28% | -$139K | ﹤0.01% | 7861 |
|
|
2015
Q2 | $454K | Buy |
+3,675
| New | +$500K | ﹤0.01% | 7809 |
|
Other funds holding CTSO
CM
Jeff Yass's CTSO Position: Q2 2026 in Review
Jeff Yass sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 1,497 shares — an estimated $17K sold.
Jeff Yass first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.
- Jeff Yass reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 1,497 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
- Jeff Yass first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
- Jeff Yass's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
- 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.